Outcome | Study Group (n = 28) | Control Group (n = 20) | p-value | |
---|---|---|---|---|
LOS (days) | 59 (30) | 52 (37) | 0.44 | |
30-day-mortality | 1 (3.5%) | 3 (15%) | 0.29 | |
Flap-related complications | Bleeding | 0 | 1 (5%) | 0.42 |
Hematoma | 1 (3.5%) | 1 (5%) | 1 | |
Marginal necrosis | 4 (14%) | 3 (15%) | 1 | |
Moderate flap necrosis | 2 (7%) | 0 | 0.5 | |
Flap loss >50% (severe flap necrosis) | 8 (29%) | 2 (10%) | 0.16 | |
Total | 16 (57%) | 7 (35%) | 0.15 | |
Donor Site related complications | Seroma (latissimus dorsi cases) | 6/15 (40%) | 2/6 (33%) | 1 |
Wound dehiscence | 1 (3.5%) | 3 (15%) | 0.3 | |
Necrosis | 1 (4%) | 1 (5%) | 1 | |
Total | 8 (29%) | 6 (30%) | 1 |